Avantor (NYSE:AVTR) Downgraded by TheStreet

Avantor (NYSE:AVTRGet Rating) was downgraded by TheStreet from a “b-” rating to a “c+” rating in a note issued to investors on Wednesday, TheStreetRatingsTable reports.

Several other research analysts have also issued reports on AVTR. The Goldman Sachs Group cut their target price on shares of Avantor from $42.00 to $37.00 and set a “buy” rating for the company in a research report on Thursday, July 14th. Cowen downgraded shares of Avantor from an “outperform” rating to a “market perform” rating and lowered their price target for the stock from $39.00 to $28.00 in a research note on Wednesday, September 14th. Morgan Stanley lowered their price target on shares of Avantor from $40.00 to $37.00 and set an “overweight” rating for the company in a research note on Monday, August 1st. Citigroup lowered their price target on shares of Avantor from $32.00 to $28.00 and set a “neutral” rating for the company in a research note on Wednesday, September 14th. Finally, Raymond James lowered their price target on shares of Avantor from $40.00 to $36.00 and set an “outperform” rating for the company in a research note on Monday, August 1st. Four research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $33.43.

Avantor Stock Down 1.6 %

Shares of NYSE:AVTR opened at $20.95 on Wednesday. Avantor has a 52-week low of $20.78 and a 52-week high of $44.37. The firm has a fifty day moving average of $26.85 and a 200 day moving average of $30.06. The firm has a market capitalization of $14.12 billion, a PE ratio of 22.53, a price-to-earnings-growth ratio of 1.91 and a beta of 1.34. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.05 and a current ratio of 1.64.

Avantor (NYSE:AVTRGet Rating) last announced its earnings results on Thursday, July 28th. The company reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by ($0.01). Avantor had a return on equity of 27.14% and a net margin of 8.27%. The company had revenue of $1.91 billion during the quarter, compared to analysts’ expectations of $1.98 billion. During the same quarter last year, the firm posted $0.35 earnings per share. The firm’s revenue was up 2.7% on a year-over-year basis. As a group, research analysts anticipate that Avantor will post 1.45 EPS for the current fiscal year.

Institutional Investors Weigh In On Avantor

A number of institutional investors have recently made changes to their positions in the company. Waratah Capital Advisors Ltd. lifted its position in Avantor by 93.3% during the fourth quarter. Waratah Capital Advisors Ltd. now owns 509,213 shares of the company’s stock valued at $21,458,000 after purchasing an additional 245,803 shares during the period. Comerica Bank lifted its position in Avantor by 36.4% during the first quarter. Comerica Bank now owns 375,575 shares of the company’s stock valued at $12,293,000 after purchasing an additional 100,242 shares during the period. DekaBank Deutsche Girozentrale lifted its position in Avantor by 21.4% during the first quarter. DekaBank Deutsche Girozentrale now owns 446,015 shares of the company’s stock valued at $15,374,000 after purchasing an additional 78,513 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its position in Avantor by 6.7% during the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 135,979 shares of the company’s stock valued at $4,599,000 after purchasing an additional 8,564 shares during the period. Finally, Aaron Wealth Advisors LLC bought a new position in Avantor during the first quarter valued at approximately $201,000. Hedge funds and other institutional investors own 81.22% of the company’s stock.

About Avantor

(Get Rating)

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Further Reading

Analyst Recommendations for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.